We are live on ! Find out more
FBLG icon

FibroBiologics
FBLG

50 hedge funds and large institutions have $17.2M invested in FibroBiologics in 2024 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 6

231% more capital invested

Capital invested by funds: $5.18M → $17.2M (+$12M)

194% more funds holding

Funds holding: 17 → 50 (+33)

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

0.45% more ownership

Funds ownership: 0.07% → 0.53% (+0.45%)

Holders
50
Holders Change
+33
Holders Change %
+194.12%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
6
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$8.64M
2
State Street
State Street
Massachusetts
+$3.59M
3
CFP
Cascade Financial Partners
California
+$3M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.91M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.11M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.76M
2
HF
HRT Financial
New York
-$619K
3
Marshall Wace
Marshall Wace
United Kingdom
-$337K
4
ECM
ExodusPoint Capital Management
New York
-$277K
5
Citigroup
Citigroup
New York
-$234K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$4.59M +$8.64M +45,288 +6,862%
State Street
2
State Street
Massachusetts
$1.88M +$3.59M +18,802 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.58M +$2.91M +15,237 +2,775%
CFP
4
Cascade Financial Partners
California
$1.57M +$3M +15,753 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.1M +$2.11M +11,060 New
TW
6
Transform Wealth
Colorado
$668K +$1.28M +6,695 New
OAS
7
Optivise Advisory Services
Tennessee
$549K +$1.05M +5,505 New
RCM
8
Requisite Capital Management
Texas
$547K +$1.05M +5,486 New
AIFAIM
9
American Institute for Advanced Investment Management
Arizona
$440K +$841K +4,410 New
Bank of America
10
Bank of America
North Carolina
$402K +$768K +4,027 New
UBS Group
11
UBS Group
Switzerland
$389K +$744K +3,902 +390,200%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$342K +$654K +3,428 New
Charles Schwab
13
Charles Schwab
California
$331K +$632K +3,314 New
Osaic Holdings
14
Osaic Holdings
Arizona
$264K +$505K +2,645 New
RWB
15
RMR Wealth Builders
New Jersey
$186K +$356K +1,868 New
CIA
16
Concurrent Investment Advisors
Florida
$176K +$336K +1,764 New
N
17
Nuveen
North Carolina
$172K +$329K +1,727 New
EFL
18
ERn Financial LLC
Wisconsin
$159K +$303K +1,591 New
EFG
19
Ethos Financial Group
Pennsylvania
$127K +$243K +1,273 New
Millennium Management
20
Millennium Management
New York
$122K -$1.76M -9,245 -88%
AGM
21
Alpine Global Management
New York
$120K +$230K +1,205 New
Morgan Stanley
22
Morgan Stanley
New York
$117K +$224K +1,174 New
RhumbLine Advisers
23
RhumbLine Advisers
Massachusetts
$115K +$220K +1,153 New
NA
24
NewEdge Advisors
Louisiana
$114K +$47.7K +250 +28%
New York State Common Retirement Fund
25
New York State Common Retirement Fund
New York
$107K +$205K +1,075 New
1
2 3

FBLG Hedge Fund Activity: Q2 2024 in Review

50 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in FibroBiologics (FBLG) for Q2 2024, worth a combined $17.2M — up 231% from $5.18M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new FBLG positions and 6 closed out — a net gain of 33 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $8.64M. The largest seller was Millennium Management, cutting an estimated $1.76M.

  • 50 institutional investors held FibroBiologics (FBLG) as of Q2 2024, up from 17 in Q1 2024.
  • Funds reported $17.2M of FibroBiologics stock for Q2 2024, up 231% quarter-over-quarter.
  • 39 funds opened new FibroBiologics positions in Q2 2024 and 6 closed out, a net change of +33 holders.
  • The largest FibroBiologics buyer in Q2 2024 was BlackRock, an estimated $8.64M added.
  • The largest FibroBiologics seller in Q2 2024 was Millennium Management, an estimated $1.76M sold.

Based on aggregated 13F filings for Q2 2024.